Clinical Trials on Immune Response in New Zealand

Total 8587 results

University of New Mexico
National Center for Advancing Translational Sciences (NCATS); La Jolla Pharmaceutical...

Withdrawn

Angiotensin II vs. Vasopressin in Septic Shock

Septic Shock

United States
Lassen Therapeutics 1 PTY LTD

Recruiting

A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease

Thyroid Eye Disease | Pulmonary Fibrosis

Australia, New Zealand, Hong Kong
New York Presbyterian Brooklyn Methodist Hospital

Terminated

Effect of IV Vitamin C, Thiamine, and Steroids on Mortality of Septic Shock

Septic Shock

United States
Sunnybrook Health Sciences Centre

Completed

Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE)

Sepsis | Mortality | Bacteremia | Critically Ill | Intensive Care | Antimicrobial

New Zealand, United States, Canada, Australia, Switzerland, Saudi Arabia, Israel
Akesobio Australia Pty Ltd

Completed

A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis

Atopic Dermatitis

New Zealand, Australia
NYU Langone Health
VA Office of Research and Development

Terminated

Utility of High-Fidelity Simulation In the Education and Assessment of Residents in the Recognition and Management of the Sepsis Syndrome

Clinical Performance | Medical Knowledge

United States
Forest Laboratories

Completed

Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance

Systemic Inflammatory Response Syndrome (SIRS) | Augmented Renal Clearance (ARC)

United States, Australia
Far Eastern Memorial Hospital

Completed

Successful Treatment of Maternal Listeria Monocytogenes Bacteremia in the First Trimester

Listeria Monocytogenes

Taiwan
National Institute of General Medical Sciences...

Completed

Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in Sepsis

Sepsis

United States
University of Washington
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Individualized Response to Vitamin D Treatment Study (INVITE)

Characteristics That Modify the Response to Cholecalciferol Treatment

United States
The George Institute
National Health and Medical Research Council, Australia; Australian and New...

Completed

ADjunctive coRticosteroid trEatment iN criticAlly ilL Patients With Septic Shock (ADRENAL)

Septic Shock

Australia, Denmark, Saudi Arabia, New Zealand, United Kingdom
Beckman Coulter, Inc.

Completed

Evaluation of Monocyte Volume Distribution Width (MDW) for Early Detection of Sepsis (MDW)

Sepsis | Severe Infection

United States
Columbia University

Enrolling by invitation

Sepsis Electronic Prompting for Timely Intervention and Care for Inpatients (SEPTIC-IP)

Sepsis | Electronic Health Records | Clinical Decision Support Systems

United States
Community Medical Center, Toms River, NJ

Completed

Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in Sepsis. (ORANGES)

Septic Shock | Sepsis, Severe

United States
University of New Mexico
La Jolla Pharmaceutical Company

Recruiting

Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock (DARK-Sepsis)

Septic Shock | Vasodilatory Shock

United States
The Cooper Health System

Active, not recruiting

Caretaker vs. Blood Pressure Monitoring With Invasive Arterial Pressure Monitoring in Patients With Septic Shock

Blood Pressure

United States
Yale University

Withdrawn

Study of Low Carbohydrate Enteral Nutrition in Patients With Bacterial Septic Shock

Bacterial Sepsis

United States
Protalex, Inc.

Terminated

Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP

Idiopathic Thrombocytopenic Purpura (ITP)

Australia, New Zealand
Innate Immunotherapeutics
Syneos Health

Completed

Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis

Secondary Progressive Multiple Sclerosis

New Zealand, Australia
Eli Lilly and Company

Completed

Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic Shock

Sepsis | Septic Shock

United States
Arrowhead Pharmaceuticals

Recruiting

Study of ARO-RAGE in Healthy Subjects and Patients With Inflammatory Lung Disease

Asthma

Korea, Republic of, New Zealand, Australia, Poland, Thailand, Spain
George A. Kaysen, M.D.
Beth Israel Medical Center

Terminated

The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis Patients (ICM)

Hypoalbuminemia

United States
CSL Limited

Completed

Subcutaneous Ig NextGen 16% in PID Patients

Primary Immunodeficiency (PID)

Australia, New Zealand
Weill Medical College of Cornell University
National Heart, Lung, and Blood Institute (NHLBI); New York Presbyterian Hospital and other collaborators

Completed

Mitochondrial DNA as a Biomarker of Sepsis Severity (MBOSS)

Sepsis | Septic Shock | Severe Sepsis | Infection | Sepsis Syndrome

United States
Solarea Bio, Inc

Recruiting

SBD121, a Synbiotic Medical Food for RA Management

Rheumatoid Arthritis

Australia, New Zealand
Intellia Therapeutics

Active, not recruiting

NTLA-2002 in Adults With Hereditary Angioedema (HAE) (NTLA-2002)

Hereditary Angioedema

France, New Zealand, Germany, United Kingdom, Netherlands, Australia
Arrowhead Pharmaceuticals

Recruiting

Study of ARO-MUC5AC in Healthy Subjects and Patients With Muco-Obstructive Lung Disease

Chronic Obstructive Pulmonary Disease | Asthma

Korea, Republic of, Australia, New Zealand, Poland, Thailand, Spain
DePuy International

Terminated

A Multi-centre Study to Assess the Long-term Performance of the Summit™ Hip in Primary Total Hip Replacement

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Post-traumatic Arthritis | Congenital Hip Dysplasia | Slipped Capital Femoral Epiphysis | Collagen Disorders | Traumatic Femoral Fractures | Nonunion of Femoral Fractures

China, Hong Kong, Italy, Korea, Republic of, New Zealand
National Taiwan University Hospital
Far Eastern Memorial Hospital

Unknown

A Prospective Observational Study of Patients With Drug Resistant Acinetobacter Baumannii Bacteremia (ANTI-AB)

Acinetobacter Bacteraemia

Taiwan
Dascena
National Institute on Alcohol Abuse and Alcoholism (NIAAA); Baystate Health; Cape... and other collaborators

Recruiting

Machine Learning Sepsis Alert Notification Using Clinical Data (HindSight P2)

Sepsis | Septic Shock | Severe Sepsis

United States
National Institute of General Medical Sciences...

Completed

Clinical Trial of the Optimal Endpoint of Early Sepsis Resuscitation (LactATES)

Septic Shock | Severe Sepsis

United States
University Health Network, Toronto

Active, not recruiting

A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer (NEO)

Ovarian Cancer | Fallopian Tube Cancer | Neoadjuvant Treatment | Debulking Surgical Procedures

Canada, United Kingdom, Spain, New Zealand
Beckman Coulter, Inc.

Completed

Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC

Sepsis | Severe Sepsis | Emergency Department | Adult Disease

United States
The George Institute
National Health and Medical Research Council, Australia; Australian and New...

Completed

Beta-Lactam InfusioN Group Study (BLING III)

Sepsis

Belgium, Australia, United Kingdom, New Zealand, France, Malaysia, Sweden
Lady Hardinge Medical College

Completed

Role of Antibiotics in Preventing Infection in Babies Born Through Meconium Stained Liquor (AbProM)

Neonatal Sepsis

India
Murdoch Childrens Research Institute
University of Otago; Sydney Children's Hospitals Network; Royal Children's Hospital and other collaborators

Completed

Improving Dosing of Vancomycin in Young Infants With Infections (VANCAPP)

Sepsis | Bacteremia | Infection

Australia
Murdoch Childrens Research Institute
Royal Children's Hospital; Royal Hospital For Women

Completed

RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates

Sepsis | Bacteremia | Infection

Australia
Columbia University

Enrolling by invitation

Sepsis Electronic Prompting for Timely Intervention and Care for Emergency Department Patients (SEPTIC-ED)

Sepsis | Electronic Health Records | Clinical Decision Support Systems

United States
Christiana Care Health Services
Therapeutic Monitoring Systems; MaRS Discovery District

Completed

The AVERT Sepsis Investigation (AVERT)

Sepsis | Severe Sepsis

United States, Canada
Beth Israel Deaconess Medical Center
The Cooper Health System; Carolinas Medical Center

Withdrawn

Pilot Study of Bevacizumab (Avastin) in Patients With Septic Shock

Septic Shock

United States
Cheetah Medical Inc.

Completed

Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis (COMMIT)

Sepsis

United States
Christiana Care Health Services

Completed

Preemptive Resuscitation for Eradication of Septic Shock

Sepsis | Severe Sepsis

United States
Atara Biotherapeutics
National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center

Completed

Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies

EBV-induced Lymphomas | EBV-associated Malignancies | Transplant Patients With EBV Viremia at High Risk of Developing a Recurrent EBV Lymphoma

United States
Emory University
The Marcus Foundation

Completed

Vitamin C, Thiamine, and Steroids in Sepsis (VICTAS)

Sepsis

United States
Hoffmann-La Roche

Completed

A Study of Subcutaneously Administered Tocilizumab in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Canada, New Zealand, Spain
Trans Tasman Radiation Oncology Group
Australasian Leukaemia and Lymphoma Group; Australasian Radiation Oncology... and other collaborators

Completed

Chemotherapy and Radiotherapy for Osteolymphoma

Osteolymphoma

Australia, New Zealand
Brigham and Women's Hospital

Completed

BK Treatment Study

BK Viremia

United States
Institute of Liver and Biliary Sciences, India

Not yet recruiting

Efficacy and Safety of Vasopressin Versus Terlipressin as a Second Vasopressor in Critically Ill Cirrhotics With Septic Shock- the VITEL-C Trial

Septic Shock | Cirrhosis, Liver

India
Memorial Sloan Kettering Cancer Center
Atara Biotherapeutics

Completed

Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

Cytomegalovirus

United States
Regeneron Pharmaceuticals
Sanofi

Completed

Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

Germany, New Zealand, Australia

Clinical Trials on Immune Response in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations